Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Blood (2016) 128 (22): 1754.

https://doi.org/10.1182/blood.V128.22.1754.1754

Published: 2016

Journal Articles

Significance of a Critical Set of 11q Chromosome Aberrations for Diagnosis of MYC Negative Burkitt Lymphoma

Grzegorz Rymkiewicz, MD PhD, Magdalena Chechlinska, Beata Grygalewicz, Barbara Pienkowska-Grela, Katarzyna Blachnio, Zbigniew Bystydzienski, Joanna Romejko-Jarosinska, MD PhD, Beata Sledz-Gawronska, Michalina Zajdel, Katarzyna Domanska-Czyz, Renata Woroniecka, Kinga Sikorska-Mali, Jan Konrad Siwicki, Monika Prochorec-Sobieszek, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 2679.

https://doi.org/10.1182/blood.V126.23.2679.2679

Published: 2015

Journal Articles

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Beata Ostrowska, MD PhD, Martyna Kotarska, MD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Anna Borawska, MD PhD, Agnieszka Druzd-Sitek, MD PhD, Ewa Paszkiewicz-Kozik, MD PhD, Lidia Poplawska, Grzegorz Rymkiewicz, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 5040.

https://doi.org/10.1182/blood.V126.23.5040.5040

Published: 2015

Journal Articles

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study.

Sergiusz Markowicz, PhD, Anna Jakubowska-Mucka, MSc, Marzena Biernacka, MSc, Grzegorz Rymkiewicz, MD, Anna Borawska, MD, Irena Federowicz, MD, Danuta Rozewska, MD, Maria Sawadro-Rochowska, MSc, Hanna Polowniak-Pracka, MD, Michal Szymczyk, MD, Henryk Skurzak, MD, Zygmunt Pojda, MD, Jan Walewski, MD

Blood (2006) 108 (11): 5187.

https://doi.org/10.1182/blood.V108.11.5187.5187

Published: 2006

Journal Articles

Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma.

Grzegorz Rymkiewicz, MD, Renata Woroniecka, MS, Katarzyna Blachnio, MS, Barbara Pienkowska-Grela, MD, PhD, Jan Walewski, MD, PhD

Blood (2005) 106 (11): 4659.

https://doi.org/10.1182/blood.V106.11.4659.4659

Published: 2005

NARROW

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Significance of a Critical Set of 11q Chromosome Aberrations for Diagnosis of MYC Negative Burkitt Lymphoma

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study.

Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Significance of a Critical Set of 11q Chromosome Aberrations for Diagnosis of MYC Negative Burkitt Lymphoma

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study.

Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only